Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker NERV
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Matthew D. Perry | 5.05M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Coastlands Capital LLC | 5.05M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Coastlands Capital GP LLC | 5.05M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Coastlands Capital Partners LP | 5.05M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Coastlands Capital LP | 5.05M | 10.0% | SCHEDULE 13G/A ↗ |
| Oct 27, 2026 | SCHEDULE 13G | NERV Minerva Neurosciences, Inc | BlackRock, Inc. | 2.45M | 5.1% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Dmitry Balyasny | 4.65M | 10.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Dames GP LLC | 4.65M | 10.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Balyasny Asset Management Holdings LP | 4.65M | 10.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Bam GP LLC | 4.65M | 10.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Balyasny Asset Management L.P. | 4.65M | 10.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Mark C. Wehrly | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | John R. Warren | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Andrew J. M. Spokes | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Daniel S. Short | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Edric C. Saito | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Roberts, Jr., Thomas G. | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Luo Patrick (Cheng) | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Michael G. Linn | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | David T. Kim | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Avner A. Husen | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Nicolas Giauque | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Varun N. Gehani | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Hannah E. Dunn | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Philip D. Dreyfuss | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Joshua J. Dapice | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Farallon F5 (GP), L.L.C. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Farallon Institutional (GP) V, L.L.C. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Farallon Partners, L.L.C. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Farallon Capital F5 Master I, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Farallon Capital (AM) Investors, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Farallon Capital Offshore Investors II, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Four Crossings Institutional Partners V, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Farallon Capital Institutional Partners III, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Farallon Capital Institutional Partners II, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Farallon Capital Institutional Partners, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Farallon Capital Partners, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Farallon Capital Management, L.L.C. | 4.73M | 9.7% | SCHEDULE 13G/A ↗ |
| Jul 8, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | J. Christopher Donahue | 8.69M | 17.2% | SCHEDULE 13G/A ↗ |
| Jul 8, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Ann C. Donahue | 8.69M | 17.2% | SCHEDULE 13G/A ↗ |
| Jul 8, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Thomas R. Donahue | 8.69M | 17.2% | SCHEDULE 13G/A ↗ |
| Jul 8, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Voting Shares Irrevocable Trust | 8.69M | 17.2% | SCHEDULE 13G/A ↗ |
| Jul 8, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Federated Hermes, Inc. | 8.69M | 17.2% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G | NERV Minerva Neurosciences, Inc | Janus Henderson Group PLC | 4.31M | 9.9% | SCHEDULE 13G ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Dmitry Balyasny | 4.32M | 10.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Dames GP LLC | 4.32M | 10.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Balyasny Asset Management Holdings LP | 4.32M | 10.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Bam GP LLC | 4.32M | 10.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NERV Minerva Neurosciences, Inc | Balyasny Asset Management L.P. | 4.32M | 10.0% | SCHEDULE 13G/A ↗ |
| Feb 20, 2026 | SCHEDULE 13G | NERV Minerva Neurosciences, Inc | Matthew D. Perry | 4.56M | 10.0% | SCHEDULE 13G ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:56 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances